Back to mobile site

Jefferies Downgrades Avalo Therapeutics Inc. (AVTX) to Underperform

February 8, 2023 2:41 AM EST Send to a Friend
Jefferies analyst Chris Howerton downgraded Avalo Therapeutics Inc. (NASDAQ: AVTX) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login